Pages 23-25

Abstract

-

Keywords

• -

İntravenöz İlaç Kullanımına Bağlı Gelişen İzole Aort Kapak Endokarditi Olgu Sunumu

Abstract

İntravenöz (IV) ilaç kullanımı, infektif endokardit gelişimi açısından risk faktörleri arasındadır. Bu hastalarda, önceleri daha sık olarak sağ kalp kapaklarının tutulduğu bilinirken, son verilerde iki tarafın tutulumunun neredeyse eşit olduğu belirtilmektedir. Aort kapağının tutulmuş olması morbidite ve mortaliteyi belirgin olarak artırmaktadır. Bu yazıda IV feniramin maleat bağımlısı olan bir hastada gelişen, aort kapağının tutulduğu infektif endokardit olgusu sunulmuştur

Keywords

• İnfektif endokardit, intravenöz ilaç bağımlılığı

References

1. 1. Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas and Bennet’s Principles and Practice of Infectious Diseases. 6 th ed.USA. Churchill Livingstone, 2005:975-1022.
2. 2. Lodise TP Jr, McKinnon PS, Levine DP, Rybak MJ. Impact of Empirical Therapy Selection on Outcomes of Intravenous Drug Users with Methicillin Susceptible Staphylococcus aureus Infective Endocarditis. Antimicrob Agents Chemother 2007;51(10):3731-3.
3. 3. Karchmer AW. Infective endocarditis. In: Braunwald, Zipes, Libby (eds): A Textbook of Cardiovascular Medicine. 6 th Edition. W.B.
4. Saunders Co., Philadelphia, 2001: 1723-48. 4. Dressler FA, Roberts WC: Infective endocarditis in opaite addicts: Analysis of 80 cases studied at necropsy. Am J Cardiol 1989; 63: 1240.
5. 5. Pallasch J, Takahashi M, Kathryn A, et al. Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation 2005; 14; 111 (23): e394-434.
6. 6. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):394-434.
7. 7. Cicioni C, Di Luzio V, Di Emidio L, et al. Limitations and discrepancies of transthoracic and transoesophageal echocardiography compared with surgical findings in patients submitted to surgery for complications of infective endocarditis. J Cardiovasc Med 2006; 7 (9): 660-6.
8. 8. Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003; 21: 167–184.

9. 9. Carozza A, Romano G, De Feo M, et al. Infective endocarditis in intravenous drug users: prevalence of left heart involvement and changing microbiologic profile. Paper presented at: 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections; June 26–28, 2003; Chamonix, France. Abstract 53.
10. 10.Chang FY, Turnidge J. Staphylococcus aureus. In: Yu VL, Merigan TC, Barriere S, eds. Antimicrobial Chemotherapy. Baltimore: Williams and Wilkins, 1999: 389-404.